You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Rubicon Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?

RUBICON has sixty approved drugs.

There is one tentative approval on RUBICON drugs.

Summary for Rubicon
US Patents:0
Tradenames:51
Ingredients:51
NDAs:60

Drugs and US Patents for Rubicon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rubicon DORZOLAMIDE HYDROCHLORIDE dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 078395-001 Oct 28, 2008 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204028-003 Dec 7, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride SOLUTION;ORAL 216780-001 Mar 28, 2023 AT RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Rubicon CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 208170-003 May 31, 2017 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Rubicon SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 204882-001 Jun 11, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 211953-001 Aug 18, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon DICLOFENAC SODIUM diclofenac sodium TABLET, DELAYED RELEASE;ORAL 216548-001 May 11, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.